bf/NASDAQ:ONTX_icon.jpeg

NASDAQ:ONTX

Onconova Therapeutics, Inc.

  • Stock

USD

Last Close

1.00

02/04 20:00

Market Cap

14.84M

Beta: 1.77

Volume Today

1.25M

Avg: 588.32K

PE Ratio

−0.75

PFCF: −0.84

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-62.56M
-
-63.80M
1.98%
-24.02M
62.34%
-19.67M
18.13%
-24.09M
22.50%
-20.41M
15.28%
-21.50M
5.36%
-25.16M
16.99%
-16.16M
35.75%
-18.96M
17.33%
-18.95T
99,915,529.61%
depreciation and amortization
446K
-
434K
2.69%
150K
65.44%
96K
36%
88K
8.33%
55K
37.50%
14K
74.55%
13K
7.14%
14K
7.69%
14K
0%
16B
114,285,614.29%
deferred income tax
-42K
-
-20K
52.38%
44K
320%
-163K
-
-98K
-
stock based compensation
8.02M
-
5.07M
36.77%
3.79M
25.30%
3.93M
3.78%
1.71M
56.48%
1.15M
32.92%
1.05M
8.63%
369K
64.79%
576K
56.10%
1.17M
103.47%
1.30T
111,006,725.94%
change in working capital
-7.24M
-
671K
109.26%
-11.17M
1,765.13%
3.82M
134.16%
102K
97.33%
-1.07M
1,146.08%
-327K
69.35%
1.49M
556.27%
-3.59M
340.82%
1.48M
141.30%
1.77T
119,272,137.20%
accounts receivables
-1.37M
-
1.47M
207.36%
-28B
1,900,982.55%
24B
185.71%
-63B
362.50%
61K
100.00%
9B
14,753,998.36%
-1K
100.00%
11B
1,100,000,100%
inventory
-814K
-
897K
210.20%
28.00B
3,121,381.94%
-24.00B
185.71%
63B
362.51%
-61K
100.00%
-9B
14,753,998.36%
accounts payables
-1.81M
-
317K
117.54%
-606K
291.17%
1.90M
413.86%
863K
54.63%
-1.45M
268.48%
232K
115.96%
562K
142.24%
-2.08M
469.40%
1.10M
153.13%
1.76T
159,474,061.38%
other working capital
-5.44M
-
354K
106.51%
-8.38M
2,467.51%
-455K
94.57%
-454K
0.22%
-398K
12.33%
-559K
40.45%
930K
266.37%
-1.52M
263.12%
382K
125.18%
-1.77T
463,350,885.34%
other non cash items
-4K
-
-6K
50%
-22K
266.67%
-3.99M
18,027.27%
-1.63M
59.18%
-2.26M
38.70%
-63K
97.21%
208K
430.16%
-321K
254.33%
98K
130.53%
-301B
307,142,957.14%
net cash provided by operating activities
-61.38M
-
-57.65M
6.09%
-31.24M
45.81%
-15.81M
49.38%
-23.82M
50.64%
-22.70M
4.72%
-20.83M
8.22%
-23.07M
10.77%
-19.49M
15.55%
-16.29M
16.39%
-17.93T
110,052,680.16%
investments in property plant and equipment
-609K
-
-228K
62.56%
-55K
-
-15K
72.73%
-14B
-
acquisitions net
purchases of investments
-39.99M
-
sales maturities of investments
40M
-
other investing activites
net cash used for investing activites
-40.60M
-
39.77M
197.96%
-55K
-
-15K
72.73%
-14B
-
debt repayment
common stock issued
79.81M
-
7.46M
-
17.42M
133.39%
6.36M
63.49%
35.07M
451.38%
21.76M
37.95%
9.06M
58.35%
55.04M
507.38%
common stock repurchased
dividends paid
other financing activites
653K
-
1.46M
124.04%
3K
-
589K
-
4.89M
730.05%
10.29M
110.57%
519K
94.96%
net cash used provided by financing activities
80.46M
-
1.46M
98.18%
7.46M
410.18%
17.42M
133.43%
6.36M
63.50%
35.66M
460.64%
26.65M
25.27%
19.36M
27.36%
55.56M
187.03%
effect of forex changes on cash
1K
-
-14K
1,500%
-9K
35.71%
-9K
0%
34K
477.78%
-15K
144.12%
-6K
60%
32K
633.33%
-28K
187.50%
-19K
32.14%
net change in cash
-21.52M
-
-16.43M
23.66%
-23.78M
44.78%
1.60M
106.73%
-17.43M
1,188.44%
12.95M
174.29%
5.76M
55.54%
-3.70M
164.30%
36.05M
1,073.93%
-16.31M
145.26%
-17.94T
109,949,020.33%
cash at beginning of period
81.53M
-
60.01M
26.39%
43.58M
27.37%
19.80M
54.57%
21.45M
8.34%
4.02M
81.24%
16.97M
321.72%
22.73M
33.92%
19.02M
16.29%
55.07M
189.46%
38.76T
70,377,601.11%
cash at end of period
60.01M
-
43.58M
27.37%
19.80M
54.57%
21.40M
8.09%
4.02M
81.20%
16.97M
321.72%
22.73M
33.92%
19.02M
16.29%
55.07M
189.46%
38.76M
29.62%
20.82T
53,721,808.30%
operating cash flow
-61.38M
-
-57.65M
6.09%
-31.24M
45.81%
-15.81M
49.38%
-23.82M
50.64%
-22.70M
4.72%
-20.83M
8.22%
-23.07M
10.77%
-19.49M
15.55%
-16.29M
16.39%
-17.93T
110,052,680.16%
capital expenditure
-609K
-
-228K
62.56%
-55K
-
-15K
72.73%
-14B
-
free cash flow
-61.99M
-
-57.88M
6.64%
-31.24M
46.03%
-15.81M
49.38%
-23.82M
50.64%
-22.70M
4.72%
-20.89M
7.97%
-23.09M
10.55%
-19.49M
15.60%
-16.29M
16.39%
-17.95T
110,138,601.36%

All numbers in USD (except ratios and percentages)